QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pfizer-to-raise-metsera-bid-after-court-denies-attempt-to-block-rival-deal

Delaware court denies Pfizer bid to block Metsera's Novo Nordisk deal as FTC flags antitrust risks and Pfizer prepares a hi...

Core News & Articles

https://www.ft.com/content/52216b29-9f22-4338-85a7-eacfc33103a1

Core News & Articles

https://www.ft.com/content/ae3297f3-4dd1-4c8a-b9c5-9c3717d34c52 

Core News & Articles

"Metsera is gratified by the Delaware Court of Chancery's decision to deny Pfizer's request for a temporary restrai...

Core News & Articles

-Reuters Citing FTC Letter To Metsera

Core News & Articles

-Reuters Citing Metsera Letter To Court

Core News & Articles

-Reuters Citing Letter To Court

 novo-pfizer-are-battling-to-buy-the-future-of-weight-loss--but-viking-already-owns-it

Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nor...

 pfizer-novo-nordisk-intensify-fight-for-metsera-as-buyout-offers-continue-to-climb

Novo Nordisk boosts its Metsera bid to $62.20 per share, valuing the company at $10 billion and outbidding Pfizer in the escala...

Core News & Articles

-Reuters Citing Conf. Call

Core News & Articles

 - Reuters Citing Court Filing

Core News & Articles

- Reuters

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION